Evidence map›Paper›PMID 38802436›Full record

Observational studyScientific reports2024

First external validity study of the Fagotti score in ovarian cancer.

Sarah Aida, Mathieu Levaillant, Henri Azaïs, Marcos Ballester, Geoffroy Canlorbe, Pauline Chauvet, Tristan Gauthier, Cyrille Huchon, Yohan Kerbage, Martin Koskas and 5 more

Erratum issuedAbstract readMulticenter StudyObservational StudyValidation Study
In one paragraph

Observational study in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Sarah AidaDepartment of Gynecology, University Hospital, 49100, Angers, France.ORCID http://orcid.org/0000-0001-9114-5392
Mathieu LevaillantDepartment of Public Health, University Hospital, 49100, Angers, France.ORCID http://orcid.org/0000-0003-2124-9801
Henri AzaïsDepartment of Gynecology and Breast Oncological Surgery, Georges-Pompidou European Hospital, APHP Centre, University of Paris, 75015, Paris, France.ORCID http://orcid.org/0000-0002-6855-9754
Marcos BallesterDepartment of Gynecology, University Hospital, Diaconnesses La Croix Simon, 75012, Paris, France.ORCID http://orcid.org/0000-0002-7737-0638
Geoffroy CanlorbeDepartment of Gynecology, University Hospital, APHP- La Pitié Salpêtrière, 75013, Paris, France.ORCID http://orcid.org/0000-0003-2653-4097
Pauline ChauvetDepartment of Gynecology, University Hospital, 63000, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0001-9103-860X
Tristan GauthierDepartment of Gynecology, University Hospital, 87042, Limoges, France.ORCID http://orcid.org/0000-0002-9688-0385
Cyrille HuchonDepartment of Gynecology, Lariboisière Hospital, AP-HP, University of Paris, 75010, Paris, France.ORCID http://orcid.org/0000-0001-5334-6345
Yohan KerbageDepartment of Gynecology, University Hospital, 59000, Lille, France.ORCID http://orcid.org/0000-0002-5957-4768
Martin KoskasDepartment of Gynecology, Hospital, Bichat, Paris Cité University, 75018, Paris, France.ORCID http://orcid.org/0000-0003-3872-2810
Lise LecointreDepartment of Gynecology, University Hospital, 67200, Strasbourg, France.ORCID http://orcid.org/0000-0002-1241-3094
Lobna OuldamerDepartment of Gynecology, University Hospital, Bretonneau, 37044, Tours, France.ORCID http://orcid.org/0000-0001-9465-0335
Émilie RaimondDepartment of Gynecology, University Hospital, 51100, Reims, France.ORCID http://orcid.org/0000-0003-2860-5450
Vincent LavouéDepartment of Gynecology, University Hospital, 35033, Rennes, France.ORCID http://orcid.org/0000-0002-4682-2806
Guillaume LegendreDepartment of Gynecology, University Hospital, 49100, Angers, France. Guillaume.legendre@chu-angers.fr.ORCID http://orcid.org/0000-0001-6787-6531

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial ovarian cancer is mostly discovered at the stage of peritoneal carcinosis. Complete cytoreductive surgery improves overall survival. The Fagotti score is a predictive score of resectability based on peritoneal laparoscopic exploratory. Our aim was to study the inter-observer concordance in an external validation of the Fagotti score. An observational, prospective, multicenter study was conducted using the Francogyn research network. The primary outcome was inter-observer concordance of the Fagotti score. 15 patients in which an ovarian mass was discovered were included. For each patient, the first exploratory laparoscopy before any treatment/chemotherapy was recorded. This bank of 15 videos was subject to blind review accompanied by a Fagotti score rating by 11 gynecological surgeons specializing in oncology. A total of 165 blind reviews were performed. Inter-observer concordance was very good for the Fagotti score with an intraclass correlation coefficient (ICC) of 0.83 [95% CI 0.71; 0.93]. Inter-observer concordance for the adjusted Fagotti score, which accounts for unexplorable areas with extensive carcinomatosis, resulted in an ICC of 0.64 [95% CI 0.46; 0.82]. According to the reviewers, the three least explorable parameters were mesentery involvement, stomach infiltration and liver damage. The ICC of the explorable Fagotti score, i.e. score with deletion of the parameters most often unexplored by laparoscopy, was 0.86 [0.75-0.94]. This study confirms the reproducibility of the Fagotti score during first assessment laparoscopies in cases of advanced ovarian cancer. The explorable Fagotti score has an equivalent or better inter-observer concordance than the Fagotti score.

Indexed as

Ovarian NeoplasmsAdultAgedCarcinoma, Ovarian EpithelialCytoreduction Surgical ProceduresFemaleHumansLaparoscopyMiddle AgedObserver VariationProspective StudiesReproducibility of Results

Identifiers

PMID38802436
PMCPMC11130284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.